The intradialytic activation of leukocytes is a major cause of hemodialysis (HD)-associated complications. Contact between blood and HD membranes frequently induces the formation of microaggregates composed of activated platelets and leukocytes, causing leukocyte activation that includes the generation of reactive oxygen species (ROS). This complex formation is mediated primarily by the interaction between P-selectin on activated platelets and its counter-ligands on leukocytes.
Objective
We examined the preventive effects of α-tocopherol and glycyrrhizin in vitro against platelet-neutrophil microaggregate formation and neutrophil ROS production induced by HD membranes.
Methods and Results
Microaggregate formation induced by the incubation of heparinized whole blood with polysulfone (PS) HD membranes was effectively inhibited by α-tocopherol and glycyrrhizin. α-Tocopherol, but not glycyrrhizin, was found to inhibit PS membrane-induced P-selectin expression on the platelet surface; however, glycyrrhizin did inhibit both the formation of neutrophil-platelet microaggregates induced by adenosine diphosphate (ADP) and the adhesion of HL60 leukemic cells to P-selectin-expressing Chinese hamster ovary (CHO) cells, suggesting that glycyrrhizin acts as a competitive inhibitor of P-selectin-mediated cell adhesion. Finally, these compounds almost completely abrogated PS membrane-induced and platelet-dependent ROS production by neutrophils.
Conclusions
These results suggest that α-tocopherol and glycyrrhizin may function as preventive agents of HD-associated leukocyte activation though the modulation of platelet-leukocyte interaction.
HimmelfarbJ., AultK., HolbrookD., LeeberD., HakimR.. Intradialytic granulocyte reactive oxygen species production: a prospective, crossover trial.J Am Soc Nephrol1993; 4: 178–86.
3.
Capeillere-BlandinC., DelaveauT., Descamps-LatschaB.. Structural modifications of human β2 microglobulin treated with oxygen-derived radicals.Biochem J1991; 277(Pt 1): 175–82.
4.
UsbertiM., GerardiG.M., GazzottiR.M.. Oxidative stress and cardiovascular disease in dialyzed patients.Nephron2002; 91: 25–33.
5.
HakimR.M.. Clinical implications of hemodialysis membrane biocompatibility.Kidney Int1993; 44: 484–94.
6.
HörlW.H.. Hemodialysis membranes: interleukins, biocompatibility, and middle molecules.J Am Soc Nephrol2002; 13(Suppl 1): S62–71.
7.
ArnaoutM., HakimR., ToddRF3rd, DanaN., ColtenH.. Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis.N Engl J Med1985; 312: 457–62.
8.
HimmelfarbJ., LazarusJ.M., HakimR.. Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis.Am J Kidney Dis1991; 17: 271–76.
BonominiM., StuardS., CarrenoM.P., SettefratiN., SantarelliP., Haeffner-CavaillonN., AlbertazziA.. Neutrophil reactive oxygen species production during hemodialysis: role of activated platelet adhesion to neutrophils through P-selectin.Nephron1997; 75: 402–11.
11.
ItohS., SusukiC., TsujiT.. Platelet activation through interaction with hemodialysis membranes induces neutrophils to produce reactive oxygen species.J Biomed Mater Res A2006; 77: 294–303.
12.
StuardS., BonominiM., SettefratiN., AlbertazziA.. Platelet-neutrophil interactions during hemodialysis: a proposed biocompatibility approach.Int J Artif Organs1998; 21: 75–82.
13.
RufA., PatschekeH.. Platelet-induced neutrophil activation: platelet-expressed fibrinogen induces the oxidative burst in neutrophils by an interaction with CD11C/CD18.Br J Haematol1995; 90: 791–6.
14.
EhlersR., UstinovV., ChenZ., ZhangX., RaoR., LuscinskasF.W., LopezJ., PlowE., SimonDl. Targeting platelet-leukocyte interactions: identification of the integrin Mac-1 binding site for the platelet counter receptor glycoprotein Ibα.J Exp Med2003; 198: 1077–88.
15.
StenbergP.E., McEverR.P., ShumanM.A., JacquesY.V., BaintonD.F.. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation.J Cell Biol1985; 101: 880–6.
16.
McEverR.P., BecksteadJ.H., MooreK.L., Marshall-CarlsonL., BaintonD.F.. GMP-140, a platelet α-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies.J Clin Invest1989; 84: 92–9.
17.
SakoD., ChangX.J., BaroneK.M., VachinoG., WhiteH.M., ShawG., VeldmanG.M., BeanK.M., AhernT.J., FurieB.. Expression cloning of a functional glycoprotein ligand for P-selectin.Cell1993; 75: 1179–86.
NagataK., TsujiT., TodorokiN.. Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62).J Immunol1993; 151: 3267–73.
20.
KoikeJ., NagataK., KudoS., TsujiT., IrimuraT.. Density-dependent induction of TNF-α release from human monocytes by immobilized P-selectin.FEBS Lett2000; 477: 84–8.
21.
NagataK., TsujiT., MatsushimaK., HanaiN., IrimuraT.. Re-distribution of selectin counter-ligands induced by cytokines.Int Immunol2000; 12: 487–92.
22.
BurtonG.W., IngoldK.U.. Vitamin E as an in vitro and in vivo antioxidant.Ann N Y Acad Sci1989; 570: 7–22.
23.
FreedmanJ.E., FarhatJ.H., LoscalzoJ., KeaneyJ.F.Jr.. α-Tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism.Circulation1996; 94: 2434–40.
24.
MuroharaT., IkedaH., OtsukaY.. Inhibition of platelet adherence to mononuclear cells by α-tocopherol: role of P-selectin.Circulation2004; 110: 141–8.
25.
LeeC.H., ParkS.W., KimY.S., KangS.S., KimJ.A., LeeS.H., LeeS.M.. Protective mechanism of glycyrrhizin on acute liver injury induced by carbon tetrachloride in mice.Biol Pharm Bull2007; 30: 1898–904.
26.
NakataN., TakaokaK.. Use of glycyrrhizin in prevention of tissue damage caused by ischemia-reperfusion in rabbit hind limbs.J Orthop Sci2006; 11: 375–9.
27.
ShinY.W., BaeE.A., LeeB., LeeS.H., KimJ.A., KimY.S., KimD.H.. In vitro and in vivo antiallergic effects of Glycyrrhiza glabra and its components.Planta Med2007; 73: 257–61.
28.
HaradaS.. The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope.Biochem J2005; 392: 191–9.
29.
van RossumT.G., VultoA.G., de ManR.A., BrouwerJ.T., SchalmS.W.. Review article: glycyrrhizin as a potential treatment for chronic hepatitis C.Aliment Pharmacol Ther1998; 12: 199–205.
30.
RaoB.N., AndersonM.B., MusserJ.H.. Sialyl Lewis X mimics derived from a pharmacophore search are selectin inhibitors with anti-inflammatory activity.J Biol Chem1994; 269: 19663–6.
31.
KimM.K., BrandleyB.K., AndersonM.B., BochnerB.S.. Antagonism of selectin-dependent adhesion of human eosinophils and neutrophils by glycomimetics and oligosaccharide compounds.Am J Respir Cell Mol Biol1998; 19: 836–41.
32.
KilgoreK.S., TanhehcoE.J., ParkJ.L., NaylorK.B., AndersonM.B., LucchesiB.R.. Reduction of myocardial infarct size in vivo by carbohydrate-based glycomimetics.J Pharmacol Exp Ther1998; 284: 427–35.
33.
ShodaiT., SuzukiJ., KudoS.. Inhibition of P-selectin-mediated cell adhesion by a sulfated derivative of sialic acid.Biochem Biophys Res Commun2003; 312: 787–93.
34.
WangP., LiS.F., LeeK.H.. Determination of glycyrrhizic acid and 18–β-glycyrrhetinic acid in biological fluids by micellar electrokinetic chromatography.J Chromatogr A1998; 811: 219–24.
35.
YonezawaY., SunadaH., OtsukaA., NakagakiM.. Physicochemical properties of glycyrrhizic acid in aqueous media. V. Critical micelle concentration of mixed solutions of glycyrrhizin and sodium cholate.Yakugaku Zasshi1983; 103: 1085–90.
36.
CachiaO., BennaJ.E., PedruzziE., DescompsB., Gougerot-PocidaloM.A., LegerC.L.. α-Tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47phox membrane translocation and phosphorylation.J Biol Chem1998; 273: 32801–5.
37.
AkamatsuH., KomuraJ., AsadaY., NiwaY.Mechanism of anti-inflammatory action of glycyrrhizin: effect on neutrophil functions including reactive oxygen species generation.Planta Med1991; 57: 119–21.
38.
AkiyamaS., InagakiM., TsujiM.. Comparison of effect of vitamin E-coated dialyzer and oral vitamin E on hemodialysis-induced Cu/Zn-superoxide dismutase.Am J Nephrol2005; 25: 500–6.
39.
BaragettiI., FurianiS., VettorettiS.. Role of vitamin E-coated membrane in reducing advanced glycation end products in hemodialysis patients: a pilot study.Blood Purif2006; 24: 369–76.
40.
CalòL., NasoA., PagninE.. Vitamin E-coated dialyzers reduce oxidative stress related proteins and markers in hemodialysis - a molecular biological approach.Clin Nephrol2004; 62: 355–61.
